Short-Term Outcomes After Switching to Budesonide/Glycopyrronium/Formoterol in Older Men with Chronic Obstructive Pulmonary Disease, Including Those with Asthma–COPD Overlap
International Journal of Chronic Obstructive Pulmonary Disease · 2026-11 · Volume 21 · 1-9
DOI: 10.2147/copd.s632932 ↗At a glance
Journal article in International Journal of Chronic Obstructive Pulmonary Disease, 2026-11. Written by Ken Shirahase and 7 co-authors. The full text is freely available (open access, CC BY-NC 3.0).
Topics: COPD
Abstract (original language)
Intet abstract tilgængeligt.
Cite
APA
Shirahase, K., Nagasaki, T., Hanada, S., Iwai, M., Tsutsumi, Y., Matsumoto, H., Muraki, M., & Tohda, Y. (2026). Short-Term Outcomes After Switching to Budesonide/Glycopyrronium/Formoterol in Older Men with Chronic Obstructive Pulmonary Disease, Including Those with Asthma–COPD Overlap. International Journal of Chronic Obstructive Pulmonary Disease, Volume 21, 1-9. https://doi.org/10.2147/copd.s632932
Vancouver
Shirahase K, Nagasaki T, Hanada S, Iwai M, Tsutsumi Y, Matsumoto H, et al. Short-Term Outcomes After Switching to Budesonide/Glycopyrronium/Formoterol in Older Men with Chronic Obstructive Pulmonary Disease, Including Those with Asthma–COPD Overlap. International Journal of Chronic Obstructive Pulmonary Disease. 2026;Volume 21:1-9. doi:10.2147/copd.s632932
BibTeX
@article{Shirahase2026,
author = {Shirahase, Ken and Nagasaki, Tadao and Hanada, Soichiro and Iwai, Masamichi and Tsutsumi, Yuki and Matsumoto, Hisako and Muraki, Masato and Tohda, Yuji},
title = {Short-Term Outcomes After Switching to Budesonide/Glycopyrronium/Formoterol in Older Men with Chronic Obstructive Pulmonary Disease, Including Those with Asthma–COPD Overlap},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2026},
volume = {Volume 21},
pages = {1--9},
doi = {10.2147/copd.s632932}
}
EUVIMED